Articles
| Open Access |
DOI: HYPOLIPIDEMIC EFFECT OF ETHANOLIC SEED EXTRACT OF BACCAUREA RAMIFLORA IN WISTER ALBINO RATS
Pritam Das , Department of Pharmacy, Jahangirnagar University, Savar, Dhaka, BangladeshAbstract
The present study investigated the hypolipidemic effect of the ethanolic seed extract of Baccaurea ramiflora in Wister albino rats. Hyperlipidemia is a major risk factor for cardiovascular diseases, and natural plant extracts have gained attention as potential therapeutic agents for managing lipid disorders. In this study, Wister albino rats were orally administered with different doses of the ethanolic seed extract for a specified duration. The lipid profile, including total cholesterol, triglycerides, low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C), was measured to assess the hypolipidemic effect of the extract.
The results demonstrated that the ethanolic seed extract of Baccaurea ramiflora significantly reduced total cholesterol, triglycerides, and LDL-C levels, while increasing HDL-C levels in hyperlipidemic rats. These findings suggest a potential hypolipidemic effect of the extract, indicating its potential use as a natural therapeutic agent for managing dyslipidemia and reducing the risk of cardiovascular diseases.
Keywords
Baccaurea ramiflora, ethanolic seed extract, hypolipidemic effect
References
Gupta A, Sehgal V, Mehan Hyperlipidemia: An updated review. Inter JBiopharmaceutical Toxicol Res. 2011;1:81-9.
Shattat GF. A review article on hyperlipidemia: types, treatments and new drug targets. Biomedical and Pharmacology Journal. 2015;7(1):399-409.
Rohilla A, Dagar N, Rohilla S, Dahiya A, Kushnoor A. Hyperlipidemia- a deadly pathological condition. Int J Curr Pharm Res. 2012;4(2):15-8.
Ruixing Y, Yuming C, Shangling P, Fengping H, Tangwei L, Dezhai Y, et al. Comparison of lipid levels, hyperlipidemia prevalence and its risk factors between Guangxi Hei Yi Zhuang and Han populations. Archives of medical research. 2006;37(6):787-93.
Mahamuni SP, Khose RD, Menaa F, Badole SL. Therapeutic approaches to drug targets in hyperlipidemia. BioMedicine. 2012;2(4):137-46.
Adam J. Improve cholesterol-HDL, the new paradigm dyslipidemia treatment. J Med Nus. 2005;26(3):200-4.
Damery S, Gratus C, Grieve R, Warmington S, Jones J, Routledge P, et al. The use of herbal medicines by people with cancer: a cross-sectional survey. British journal of cancer. 2011;104(6):927.
Dhaliya S, Surya A, Dawn V, Betty C, Arun K, Sunil C. A review of hyperlipidemia and medicinal plants. Int JA PS BMS. 2013;2(4):219-37.
Lin Y, Yi Z, Zhao Y. Chinese Dai medicine colorful illustrations. Kunming: Yunnan National Publishing House. 2003;380.
Sundriyal M, Sundriyal R. Underutilized edible plants of the Sikkim Himalaya: need for domestication. Current Science. 2003:731-6.
Council NR. Guide for the care and use of laboratory animals: National Academies Press; 2010.
Arafa HM. Curcumin attenuates diet-induced hypercholesterolemia in rats. Medical Science Monitor. 2005;11(7):BR228-BR34.
Article Statistics
Copyright License
Copyright (c) 2023 The American Journal of Medical Sciences and Pharmaceutical Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.